Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleResearch and Reports

Diagnostic Challenges in Amyloid Light-Chain Amyloidosis

Sam Mosley and Kate Moreau
American Society for Clinical Laboratory Science January 2026, 39 (1) 11-15; DOI: https://doi.org/10.29074/ascls.2026003334
Sam Mosley
Department of Biomedical and Health Sciences, University of Vermont
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: smosley{at}uvm.edu
Kate Moreau
Department of Biomedical and Health Sciences, University of Vermont
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Sam Mosley⇑
  2. Kate Moreau
  1. Department of Biomedical and Health Sciences, University of Vermont
  2. Department of Biomedical and Health Sciences, University of Vermont
  1. Address for Correspondence: Sam Mosley
    , Department of Biomedical and Health Sciences, University of Vermont, smosley{at}uvm.edu

ABSTRACT

Amyloid light-chain (AL) amyloidosis is a rare plasma cell disorder characterized by the extracellular deposition of misfolded immunoglobulin light chains, resulting in organ dysfunction and high mortality. Delayed and missed diagnoses are common owing to nonspecific, heterogeneous symptoms. Evidence shows that racial and ethnic minorities, individuals with low socioeconomic status, and patients without access to specialized centers are more likely to experience delayed diagnoses and reduced treatment access. This introduces the potential for populations affected by AL amyloidosis to be excluded from clinical cohorts. From a laboratory perspective, diagnosis relies heavily on serum and urine free light-chain assays. Reference intervals present an ongoing challenge as recommendations shift from population-specific to population-inclusive models and as organ dysfunction confounds urine-based assays. Refinement of reference intervals using diverse cohorts, development of novel assays targeting amyloidogenic light chains, risk-based stratification approaches, and artificial intelligence–based predictive models show promise for earlier disease recognition. Addressing diagnostic delays while minimizing unnecessary interventions requires coordinated improvements in laboratory testing, provider education, infrastructure, and population-based research.

ABBREVIATIONS:
  • AI - artificial intelligence
  • AL - amyloid light chain
  • ATTR-CM - transthyretin amyloid cardiomyopathy
  • dFLC - difference between involved and uninvolved light chains
  • eGFR - estimated glomerular filtration rate
  • EHR - electronic health record
  • FLC - free light chain
  • MDT - multidisciplinary team
  • MGUS - monoclonal gammopathy of undetermined significance
  • SES - socioeconomic status
  • VistA - Veterans Health Information Systems and Technology Architecture
INDEX TERMS:
  • hematology
  • immunoglobulin light chains
  • immunoglobulin light-chain amyloidosis
  • delayed diagnosis
  • Accepted July 3, 2026.

American Society for Clinical Laboratory Science

View Full Text

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 39 (1)
American Society for Clinical Laboratory Science
Vol. 39, Issue 1
1 Jan 2026
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diagnostic Challenges in Amyloid Light-Chain Amyloidosis
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Diagnostic Challenges in Amyloid Light-Chain Amyloidosis
Sam Mosley, Kate Moreau
American Society for Clinical Laboratory Science Jan 2026, 39 (1) 11-15; DOI: 10.29074/ascls.2026003334

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Diagnostic Challenges in Amyloid Light-Chain Amyloidosis
Sam Mosley, Kate Moreau
American Society for Clinical Laboratory Science Jan 2026, 39 (1) 11-15; DOI: 10.29074/ascls.2026003334
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • INTRODUCTION
    • SOCIOECONOMIC BARRIERS
    • HEALTH CARE SYSTEM BARRIERS
    • CLINICAL BARRIERS
    • THE ROLE OF THE LABORATORY
    • REFERENCE INTERVALS AND RENAL CONFOUNDING
    • CONCLUSIONS
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Posttransfusion Alloimmunization Following Corticosteroid Treatment
  • Evaluating Vortexing Times to Disaggregate Platelet Clumps in EDTA Specimens
Show more Research and Reports

Similar Articles

Keywords

  • AI - artificial intelligence
  • AL - amyloid light chain
  • ATTR-CM - transthyretin amyloid cardiomyopathy
  • dFLC - difference between involved and uninvolved light chains
  • eGFR - estimated glomerular filtration rate
  • EHR - electronic health record
  • FLC - free light chain
  • MDT - multidisciplinary team
  • MGUS - monoclonal gammopathy of undetermined significance
  • SES - socioeconomic status
  • VistA - Veterans Health Information Systems and Technology Architecture
  • hematology
  • immunoglobulin light chains
  • immunoglobulin light-chain amyloidosis
  • delayed diagnosis

© 2026 The American Society for Clinical Laboratory Science

Powered by HighWire